LASIK, a laser eye surgery that corrects common vision problems by reshaping the cornea, may help treat people with mild to moderate astigmatism. However, it may not be right for everyone.

For the first time, the ZEISS MEL 90 will be showcased in the U.S. at ASCRS, extending ZEISS's LVC market leadership with treatment for myopia, hyperopia, and mixed astigmatism.

For the first time, the ZEISS MEL 90 will be showcased in the U.S. at ASCRS, extending ZEISS's LVC market leadership with treatment for myopia, hyperopia, and mixed astigmatism. "The FDA approval of ...

In January 2025, the MEL 90 excimer laser by Carl Zeiss Meditec AG received U.S. FDA approval for treating myopia, hyperopia, and mixed astigmatism, marking a significant milestone in refractive ...

Conventional LASIK parameters increase to 5 D of cylinder for myopic astigmatism, 3 D for hyperopic astigmatism, and 6 D for mixed astigmatism (VISX FDA labeling, Abbott Medical Optics, Santa Ana ...

Zeiss Medical Technology (ZMT) has announced that its MEL® 90 ophthalmology system has received approval from the U.S. Food and Drug Administration (FDA), giving the excimer laser technology ...

The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro, extending ZEISS' LVC market leadership with treatment for myopia, hyperopia, and mixed astigmatism. "The increasing global ...

The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro, extending ZEISS' LVC market leadership with treatment for myopia, hyperopia, and mixed astigmatism. DUBLIN, Calif. and JENA, ...